Dyadic International Inc.

DYAI

Healthcare Biotechnology

Dyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024.

Revenue
−61.4%
EPS
n/m
Free cash flow
n/m
Total debt
+0.80%

Quarter to September 2026, against a year earlier

0.33 0.02 −5.71%
Market cap
$14.0M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
2/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

What it owns vs. what it owes Q3 FY2026, 30 September 2026

Liabilities are $2.6M more than assets: shareholders’ equity is negative. What is a balance sheet?

30 September 2026 · total $7.9M

Owns

$65.4KLong-term assets
$7.9MOther short-term assets

Funded by

$10.5MOther liabilities

Debt is 0.0% of the total; liabilities are $2.6M more than assets.

It went from net cash of 35% of assets to net debt of 6% of assets since Q4 FY25.

Assets and net debt, three quartersTotal assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, three quarters
Q4 FY25Q1 FY26Q2 FY26
Total assets$0.0B$0.0B$0.0B
Net debt (debt less cash)$0.0B$0.0B$0.0B
Net debt ÷ assets (right axis)−35.5%−19.0%5.7%
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 13 Nov
Cash and Short Term Investments

+8 more quarters

8.55 6.52 4.67 —
Receivables
1.13 1.01 1.32 —
Total current assets
9.90 7.70 6.41 7.87
Long-Term Investments
— 0.07 — —
Long-term receivables
— — 0.11 —
Long-term assets (Other)
0.01 0.01 0.01 0.01
Total non-current assets
0.05 0.11 0.13 0.07
Total Assets
9.95 7.81 6.54 7.93
Accounts Payable
0.85 1.06 0.82 1.52
Accrued Expenses
1.07 0.99 1.50 —
Current Revenue (Deferred)
1.73 1.11 1.56 1.58
Total current liabilities
3.69 3.18 3.88 4.65
Long Term Debt (Total)
5.03 5.03 5.04 —
Total non-current liabilities
5.03 5.03 5.04 5.86
Total liabilities
8.71 8.22 8.92 10.51
Additional Paid In Capital
113.57 113.88 114.02 115.19
Common Stock (Net)
0.05 0.05 0.05 0.05
Retained Earnings
(93.45) (95.41) (97.53) (98.89)
Treasury Stock
18.93 18.93 18.93 18.93
Common Equity (Total)
1.23 (0.41) (2.39) (2.58)
Shareholders Equity (Total)
1.23 (0.41) (2.39) (2.58)
Shareholders Equity and Liabilities (Total)
9.95 7.81 6.54 7.93
Shares (Common)
36.19 36.44 36.44 40.09
Shareholders Equity (Tangible)
1.23 (0.41) (2.39) (2.58)
Net Debt
(3.53) (1.48) 0.37 —
Total Debt
5.03 5.03 5.04 —

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 13 Nov 2026